Adolescent presentation of FGFR1::EBF2 gene fusion mesenchymal tumor

被引：0
|
作者：
Jaber, Omar [1 ]
Sultan, Iyad [2 ,3 ,4 ]
机构：
[1] King Hussein Canc Ctr, Dept Pathol & Lab Med, Amman, Jordan
[2] King Hussein Canc Ctr, Artificial Intelligence & Data Innovat Off, Dept Pediat, Amman, Jordan
[3] Univ Jordan, Fac Med, Dept Pediat, Amman, Jordan
[4] Princess Sumaya Univ Technol, King Hussein Sch Comp Sci, Amman, Jordan
来源：
GENES CHROMOSOMES & CANCER | 2024年 / 63卷 / 04期
关键词：
D O I：
10.1002/gcc.23234
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors
    Li, Gary
    Krook, Melanie
    Roychowdhury, Sameek
    Avogadri, Francesca
    Ye, Yining
    Moran, Susan
    CANCER RESEARCH, 2019, 79 (13)
  • [22] FP-1039 (FGFR1:Fc), a soluble FGFR1 receptor antagonist, inhibits tumor growth and angiogenesis.
    Zhang, Hongbing
    Lorianne, Masuoka K.
    Baker, Kevin P.
    Sadra, Ali
    Bosch, Elizabeth
    Brennan, Tom
    Doberstein, Stephen
    Goodworth, Gilbert
    Hestir, Kevin
    Hollenbaugh, Diane
    Long, Li
    Qin, Minmin
    Williams, Lewis T.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3449S - 3450S
  • [23] Head and Neck Phosphaturic Mesenchymal Tumor: A Report of 5 Cases with FGFR1 Fluorescence In Situ Hybridization Analysis
    Wasserman, Jason K.
    Purgina, Bibianna
    Lai, Chi K.
    Mahaffey, Alyssa
    Gravel, Denis
    Bell, Diana
    Chiosea, Simion I.
    LABORATORY INVESTIGATION, 2016, 96 : 330A - 331A
  • [24] Characterization of FGFR1/2 genetic alterations reveals novel fusions of FGFR1 in Chinese breast cancer
    Wang, Y.
    Guo, L.
    Cao, L.
    Jia, M.
    Wen, L.
    Ren, C.
    Zhang, G.
    Liao, N.
    CANCER RESEARCH, 2019, 79 (04)
  • [25] Head and Neck Phosphaturic Mesenchymal Tumor: A Report of 5 Cases with FGFR1 Fluorescence In Situ Hybridization Analysis
    Wasserman, Jason K.
    Purgina, Bibianna
    Lai, Chi K.
    Mahaffey, Alyssa
    Gravel, Denis
    Bell, Diana
    Chiosea, Simion I.
    MODERN PATHOLOGY, 2016, 29 : 330A - 331A
  • [26] The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins
    Demiroglu, A
    Steer, EJ
    Heath, C
    Taylor, K
    Bentley, M
    Allen, SL
    Koduru, P
    Brody, JP
    Hawson, G
    Rodwell, R
    Doody, ML
    Carnicero, F
    Reiter, A
    Goldman, JM
    Melo, JV
    Cross, NCP
    BLOOD, 2001, 98 (13) : 3778 - 3783
  • [27] Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER plus breast cancer with FGFR1/2 alterations
    Uemoto, Yasuaki
    Lin, Chang-Ching A.
    Wang, Bingnan
    Ye, Dan
    Fang, Yisheng V.
    Bikorimana, Emmanuel
    Napolitano, Fabiana
    Chica-Parrado, Maria Rosario
    Li, Cheung
    Mendiratta, Saurabh
    Chen, Chuo
    Hanker, Ariella B.
    Arteaga, Carlos L.
    CANCER LETTERS, 2025, 619
  • [28] FGFR1 Gene Amplification in Squamous Cell Bronchopulmonary Carcinoma
    Salle, F. Galateau
    Le Stang, N.
    Grimaux, M.
    Leon, V.
    Kampbell, K.
    Oulkhouir, Y.
    Cotigny, S. Lecot
    Bergot, E.
    Zalcman, G.
    LABORATORY INVESTIGATION, 2014, 94 : 477A - 477A
  • [29] Mesenchymal FGFR1 and FGFR2 control patterning of the ureteric mesenchyme by balancing SHH and BMP4 signaling
    Deuper, Lena
    Meuser, Max
    Thiesler, Hauke
    Jany, Ulrich W. H.
    Rudat, Carsten
    Hildebrandt, Herbert
    Trowe, Mark-Oliver
    Kispert, Andreas
    DEVELOPMENT, 2022, 149 (17):
  • [30] FGFR1 gene amplification in small cell lung cancer
    Park, Ji Soo
    Lee, Jae-Seok
    Shim, Hyo Sup
    Kim, Hye Ryun
    Lim, Sun Min
    Kim, Joo Hang
    Cho, Byoung Chul
    CANCER RESEARCH, 2014, 74 (19)
12345